- Cryptic splice sites are splice-like sequences in RNA that are normally unused or used only rarely but can become recognized by the cellular splicing machinery under certain conditions. They are important because the correct removal of introns and joining of exons depends on accurate identification of splice sites within a pre-mRNA molecule. When a cryptic splice site becomes active, the cell may produce an RNA transcript with an altered exon or intron structure. This can change the resulting mRNA and, in some cases, disrupt protein production. Cryptic splice sites therefore provide an important connection between normal RNA splicing, alternative splicing, genetic variation, and disease.
- To understand cryptic splice sites, it is useful to first consider how normal RNA splicing occurs. During transcription, many eukaryotic genes produce a precursor RNA known as pre-mRNA, which contains exons and introns. Before the RNA can serve as mature mRNA, introns are generally removed and exons are joined. The spliceosome, a large RNA-protein complex, identifies important sequence features around introns, including the 5′ splice site, branch point, polypyrimidine tract, and 3′ splice site. These signals help determine where splicing begins and ends. Because the sequences involved are not always perfectly conserved, the spliceosome must interpret several signals together rather than relying on one short sequence alone.
- A cryptic splice site is essentially an alternative splice-like sequence that is available within the RNA but is not normally selected as the primary site. Such sequences can occur naturally within introns or exons and may resemble canonical splice sites closely enough to be recognized by the spliceosome. Under normal circumstances, stronger or more appropriately regulated splice-site signals usually prevent these sites from being used. However, changes in the sequence or regulatory environment can alter the balance between competing splice sites and allow a cryptic site to become active.
- Cryptic splice sites can occur at either side of an intron. A cryptic 5′ splice site can compete with the normal donor site, while a cryptic 3′ splice site can compete with the normal acceptor site. Their activation can therefore change the boundaries of the RNA segments that are removed or retained during splicing. Depending on where the cryptic site occurs, the mature transcript may contain a shortened exon, an extended exon, part of an intron, or another unexpected sequence arrangement. The consequences depend strongly on the location of the activated site and on the resulting RNA sequence.
- The distinction between canonical and cryptic splice sites is not always absolute. Normal splice-site selection is influenced by sequence strength, RNA structure, the surrounding regulatory elements, and the availability of splicing factors. A sequence that is rarely used in one cellular context might be used more frequently in another. In this sense, cryptic splice sites exist within a broader landscape of splice-site competition. They should therefore be distinguished from deliberately regulated alternative splice sites, although the molecular mechanisms that determine whether these sites are used can overlap.
- The spliceosome plays a central role in cryptic splice-site activation. During normal splicing, spliceosomal components recognize sequence features around an intron and assemble on the pre-mRNA. U1 snRNP is involved in recognition of the 5′ splice site, while U2 snRNP recognizes the branch-point region. Other spliceosomal components join to form the active complex that carries out the chemical reactions of intron removal and exon ligation. If a cryptic sequence provides a sufficiently suitable binding environment, spliceosomal recognition can shift toward that sequence, particularly when the canonical splice site is weakened or the surrounding regulatory environment changes.
- Splicing factors add another layer of control. RNA-binding proteins can promote or inhibit the use of particular splice sites by interacting with regulatory sequences in exons or introns. Splicing enhancers and silencers can influence whether nearby splice sites are recognized efficiently. Consequently, activation of a cryptic splice site may result not only from a direct change to the splice-site sequence but also from changes in regulatory elements that affect spliceosome recruitment or splice-site competition.
- RNA structure can also influence cryptic splice-site usage. Although splice-site recognition depends heavily on RNA sequence, the pre-mRNA folds into secondary structures that can make particular regions more or less accessible to RNA-binding proteins and spliceosomal components. A structural change may therefore alter the relative accessibility of canonical and cryptic sites. This illustrates why RNA splicing is a regulated process involving interactions between sequence, structure, proteins, and the transcriptional environment.
- One of the most important causes of cryptic splice-site activation is a splice-site mutation. A genetic variant affecting a canonical 5′ or 3′ splice site can weaken the normal site sufficiently that the spliceosome begins using another sequence nearby. In other cases, a mutation can create a new splice-like sequence that competes with the original site. The resulting RNA may therefore differ substantially from the transcript produced from the normal allele.
- Cryptic splice sites can also be activated by mutations outside the canonical splice-site sequences. Variants within exons or introns can alter splice-site strength, create new splice-like signals, disrupt splicing enhancers, or interfere with splicing silencers. A variant that appears relatively distant from a traditional splice-site boundary can therefore have an important effect on RNA processing. This is one reason why interpreting genetic variants requires consideration of their potential effects on RNA splicing rather than focusing only on whether they directly change a protein-coding sequence.
- The consequences of cryptic splice-site activation depend on how the altered RNA is processed. If a cryptic 5′ splice site is used inside an exon, part of that exon may be removed. If a cryptic 3′ splice site is activated, an unexpected portion of an intron or exon may be included in the mature RNA. These changes can modify the length and sequence of the resulting mRNA and may alter untranslated regions or protein-coding regions. In some cases, the altered transcript may still produce a functional protein, while in others the change can substantially impair protein production or function.
- A particularly important consequence occurs when cryptic splicing changes the reading frame of an mRNA. If the inserted or deleted sequence is not compatible with the original reading frame, the downstream codons can be altered. This may introduce a premature termination codon and produce an abnormal or truncated protein. Alternatively, the altered transcript may be unstable or degraded before significant protein production occurs. Thus, cryptic splice-site activation can connect a DNA sequence variant to changes in RNA processing, protein production, and ultimately cellular function.
- Cells also have mechanisms for identifying and eliminating some abnormal RNA molecules. One important pathway is nonsense-mediated decay, which can recognize certain transcripts containing premature termination codons and reduce their accumulation. As a result, a genetic variant that activates a cryptic splice site may not simply produce an abnormal protein; it may instead reduce the amount of usable mRNA available for translation. The final molecular effect therefore depends on both the altered splicing pattern and the subsequent fate of the RNA.
- Cryptic splice sites can sometimes produce changes that resemble other forms of alternative splicing. For example, activation of a cryptic site may remove part of an exon in a way that resembles exon skipping, or it may cause additional intronic sequence to remain in the mature transcript, producing an effect related to intron retention. However, cryptic splice-site activation specifically refers to the use of a previously unused or rarely used splice-like sequence. This distinction is useful when describing the molecular mechanism responsible for an abnormal transcript.
- The phenomenon is particularly important in genetic disease because many disease-causing variants affect RNA processing rather than directly changing a protein-coding codon. A mutation may weaken a canonical splice site, create a cryptic donor or acceptor site, or alter a regulatory sequence that controls splice-site recognition. The resulting abnormal transcript can reduce normal gene expression or produce an altered protein. Consequently, genetic mutations that appear difficult to interpret from DNA sequence alone may become more understandable when their effects on RNA are investigated.
- Cancer provides another important context in which abnormal splice-site selection can matter. Changes in genes encoding splicing regulators, mutations affecting splice-site sequences, and alterations in RNA-processing pathways can contribute to abnormal transcript production. Cancer cells can display changes in alternative splicing patterns that influence cell growth, survival, differentiation, and other biological processes. Cryptic splice-site usage can be one component of this broader disruption of RNA processing.
- The study of cryptic splice sites has been greatly aided by RNA sequencing. RNA-sequencing data can reveal unexpected exon boundaries, unusual junctions, partial exon usage, and other transcript structures that indicate abnormal splice-site selection. Researchers can compare RNA produced from different genetic variants or cellular conditions to determine whether a particular sequence change alters splicing. Short-read sequencing can provide extensive information about splice junctions, while long-read RNA sequencing can help connect multiple splicing events within the same transcript.
- Bioinformatics is essential for interpreting these data. Computational tools can identify splice junctions, predict potential splice sites, compare transcript structures, and estimate how genetic variants might affect splicing. When DNA sequencing identifies a variant near a gene, computational predictions can be combined with RNA-sequencing evidence and other experimental data to determine whether the variant is likely to alter RNA processing. This integrated approach is particularly valuable in genetic testing and clinical variant interpretation.
- Experimental studies can provide additional evidence for cryptic splice-site activation. Researchers may examine RNA from patient-derived cells, compare normal and variant sequences, or use laboratory systems to test how a particular genetic change affects splicing. These approaches can help distinguish a potentially harmful splice-altering variant from a sequence difference that has little functional effect. The combination of genomic, transcriptomic, computational, and experimental evidence provides a more complete picture of how genetic variation affects gene expression.
- Cryptic splice sites also demonstrate why gene expression cannot always be understood simply by following the sequence from DNA to protein. The DNA sequence contains information that is interpreted through transcription, RNA processing, splicing, and translation. A single nucleotide change can influence the processing of an RNA molecule even when it does not directly change a protein-coding codon. The resulting phenotype may therefore arise from altered RNA structure or abundance rather than from a straightforward change in the amino acid sequence.
- The regulation of cryptic splice sites is also connected to the broader organization of genes. The location of exons and introns, the strength of splice sites, nearby regulatory elements, RNA structure, transcription rate, chromatin environment, and cellular concentrations of RNA-binding proteins can all influence splice-site selection. This makes splicing a dynamic process rather than a simple recognition of fixed boundaries. Different tissues or developmental stages may therefore display different sensitivities to particular splice-altering variants.
- Therapeutic research has increasingly explored ways to correct abnormal RNA splicing. In some situations, antisense oligonucleotides can be designed to bind specific RNA sequences and alter splice-site recognition. Depending on the molecular defect, such an approach may help prevent the use of an abnormal cryptic site or encourage production of a more appropriate transcript. Splicing-directed therapies illustrate how understanding the molecular details of RNA processing can provide opportunities to intervene after a genetic variant has already been identified.
- Cryptic splice sites are also relevant to the interpretation of variants that initially appear to be harmless because they do not change an obvious protein-coding region. A sequence located within an intron or near an exon boundary may nevertheless influence RNA processing. Similarly, a synonymous variant that leaves the encoded amino acid unchanged can sometimes affect splicing by altering regulatory sequences or creating a competing splice-like signal. Genetic interpretation therefore increasingly considers the possibility that variants can affect RNA processing through mechanisms that are not apparent from protein sequence analysis alone.
- From an evolutionary perspective, the presence of cryptic splice-like sequences is not surprising because splice-site consensus sequences are not completely fixed. Genome sequences contain many regions with partial similarity to functional splice sites. Most are ignored under normal conditions because they are too weak, inaccessible, or poorly positioned relative to other regulatory signals. However, changes in sequence or cellular context can alter their usage. Some rarely used splice sites may also become incorporated into regulated alternative splicing during evolution, showing that the boundary between cryptic and alternative splicing can be influenced by biological context.
- Understanding cryptic splice sites therefore adds another layer to the study of RNA splicing. Canonical splice sites provide the main signals for intron removal, while alternative splice sites can be deliberately regulated to generate different transcripts. Cryptic splice sites represent additional splice-like signals that can become active when the normal balance of recognition is disturbed or altered. Their study helps explain how small changes in DNA or RNA can produce unexpectedly large effects on gene expression.
- The importance of cryptic splice sites becomes especially clear when considered within the wider network of pre-mRNA processing. Exons, introns, splice sites, the spliceosome, splicing factors, and regulatory RNA elements work together to determine the structure of mature RNA. Changes at any point in this network can alter the final transcript. Cryptic splice-site activation is therefore not an isolated phenomenon but part of the broader molecular system that controls how genetic information is converted into functional RNA and, where appropriate, protein.
- Ultimately, cryptic splice sites illustrate both the precision and flexibility of gene regulation. Cells must recognize the correct splice boundaries from among many similar sequences, while still retaining the ability to regulate RNA processing in different biological contexts. When this system is disrupted by genetic variants or other molecular changes, cryptic splice sites can become activated and generate abnormal transcripts. Studying these hidden splicing signals is therefore important for understanding gene expression, genetic disease, molecular diagnostics, and the development of therapies that target RNA processing.
